Sesé et al. 21 examined the transcriptional and translational regulation of hormone-refractory triple-negative breast cancer (TNBC) subtype under a combination of hypoxia and mTOR (mechanistic target of rapamycin) inhibitor treatment. The gene discussed is MTOR; the disease is triple-negative breast carcinoma.